FireGen Biomedicals key facts
- Provider of cancer screening services intended for oncology treatment.
- It has raised $29.4M; the latest was Later Stage VC in Aug 2025.
- Notable investors include GSR Ventures China, CCB International, Zhongguancun Science City, Beijing Zhongguancun Collaborative Innovation Investment Fund Management, GoldenSand Capital — 11 tracked in total.
- Status: Privately Held (backing).
Who backs FireGen Biomedicals
11+Membership and data by Private Market View
- ·The complete investor list: 11 names
- ·Watch FireGen Biomedicals: the Monday email on marks, rounds and moves
FireGen Biomedicals funding rounds
No funding rounds for FireGen Biomedicals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
FireGen Biomedicals investors
11 investors are on record for FireGen Biomedicals, including GSR Ventures China, CCB International, Zhongguancun Science City and Beijing Zhongguancun Collaborative Innovation Investment Fund Management.
About FireGen Biomedicals
Provider of cancer screening services intended for oncology treatment. The company primarily focuses on the development of genetic tumor screening, early screening, and targeted drug product development, as well as medical technology services. It mainly provides early cancer screening, tumor drug guidance, and tumor genetic risk assessment, offering innovative cancer screening solutions to patients.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2016
- Website
- fgbiomed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
FireGen Biomedicals doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.